Protein Symbol | Approved Name | Docking Scores |
Similarity Score |
Best Match | ||
---|---|---|---|---|---|---|
Model 1 | Model 2 | Model 3 | ||||
5HT1B_HUMAN | 5-hydroxytryptamine receptor 1B | -6.38 | -6.56 | -6.91 | 49.30% | CHEMBL146942 |
5HT2A_HUMAN | 5-hydroxytryptamine receptor 2A | -6.58 | -6.64 | N/A | 60.00% | CHEMBL493129 |
5HT2B_HUMAN | 5-hydroxytryptamine receptor 2B | -6.29 | -6.62 | -6.59 | 60.00% | CHEMBL493129 |
5HT2C_HUMAN | 5-hydroxytryptamine receptor 2C | -6.37 | -6.47 | N/A | 60.00% | CHEMBL493129 |
AA1R_HUMAN | adenosine A1 receptor | -6.15 | -6.23 | -6.76 | 34.00% | CHEMBL1544 |
AA2AR_HUMAN | adenosine A2a receptor | -6.66 | -6.62 | -6.52 | 39.56% | CHEMBL2042091 |
ACES_HUMAN | acetylcholinesterase (Cartwright blood group) | -6.57 | -6.43 | -6.90 | 60.32% | CHEMBL2088633 |
ACE_HUMAN | angiotensin I converting enzyme | -5.94 | -6.12 | -5.74 | 32.23% | CHEMBL254495 |
ACHA9_HUMAN | cholinergic receptor nicotinic alpha 9 subunit | -5.34 | N/A | N/A | 13.51% | CHEMBL386114 |
ACHB2_HUMAN | cholinergic receptor nicotinic beta 2 subunit | -5.26 | -6.36 | -6.39 | N/A | N/A |
ACM1_HUMAN | cholinergic receptor muscarinic 1 | -7.10 | -6.35 | N/A | 58.46% | CHEMBL4081662 |
ACM4_HUMAN | cholinergic receptor muscarinic 4 | -7.21 | -6.79 | N/A | 46.99% | CHEMBL83 |
ADRB2_HUMAN | adrenoceptor beta 2 | -6.06 | -6.77 | -7.50 | 44.33% | CHEMBL513389 |
AGTR2_HUMAN | angiotensin II receptor type 2 | -6.34 | -6.35 | -6.57 | 28.97% | CHEMBL155987 |
ALDR_HUMAN | aldo-keto reductase family 1 member B | -6.48 | -6.27 | -6.73 | 37.84% | CHEMBL77283 |
AMPN_HUMAN | alanyl aminopeptidase, membrane | -5.59 | -6.42 | -6.13 | 31.34% | CHEMBL414393 |
AOFA_HUMAN | monoamine oxidase A | -6.86 | -6.87 | -7.17 | 53.23% | CHEMBL1070 |
AOFB_HUMAN | monoamine oxidase B | -6.89 | -7.16 | -7.09 | 51.61% | CHEMBL3918471 |
BACE1_HUMAN | beta-secretase 1 | -5.16 | -5.50 | -6.00 | 45.12% | CHEMBL3672445 |
CAH2_HUMAN | carbonic anhydrase 2 | -5.65 | -5.56 | -5.38 | 57.63% | CHEMBL98253 |
CASP1_HUMAN | caspase 1 | -5.13 | -6.06 | -4.60 | 31.43% | CHEMBL1221503 |
CDK5_HUMAN | cyclin dependent kinase 5 | -7.06 | -7.24 | -7.37 | 37.21% | CHEMBL1988201 |
CHLE_HUMAN | butyrylcholinesterase | -6.40 | -6.31 | -6.54 | 42.27% | CHEMBL2381394 |
CNR1_HUMAN | cannabinoid receptor 1 | -6.60 | -6.48 | -7.42 | 53.95% | CHEMBL234209 |
CNR2_HUMAN | cannabinoid receptor 2 | -7.32 | -6.84 | N/A | 56.16% | CHEMBL1214644 |
COLI_HUMAN | proopiomelanocortin | -6.22 | -6.33 | -5.90 | N/A | N/A |
COMT_HUMAN | catechol-O-methyltransferase | -4.90 | -4.50 | -5.42 | 34.75% | CHEMBL4639358 |
CRP_HUMAN | C-reactive protein | -4.73 | -4.51 | N/A | N/A | N/A |
CXCR1_HUMAN | C-X-C motif chemokine receptor 1 | -6.95 | N/A | N/A | 26.55% | CHEMBL220182 |
CXCR4_HUMAN | C-X-C motif chemokine receptor 4 | -7.07 | -5.85 | -5.86 | 44.44% | CHEMBL126657 |
DRD2_HUMAN | dopamine receptor D2 | -6.56 | N/A | N/A | 55.13% | CHEMBL30560 |
DRD3_HUMAN | dopamine receptor D3 | -7.09 | N/A | N/A | 55.13% | CHEMBL30560 |
DRD4_HUMAN | dopamine receptor D4 | -6.17 | -6.92 | N/A | 51.19% | CHEMBL134866 |
EDN1_HUMAN | endothelin 1 | -6.16 | N/A | N/A | N/A | N/A |
ESR1_HUMAN | estrogen receptor 1 | -6.26 | -6.17 | -6.14 | 55.00% | CHEMBL205119 |
FABP5_HUMAN | fatty acid binding protein 5 | -5.82 | -4.27 | -4.41 | 38.64% | CHEMBL4292072 |
FYN_HUMAN | FYN proto-oncogene, Src family tyrosine kinase | -6.09 | N/A | N/A | 36.56% | CHEMBL221753 |
GLRA3_HUMAN | glycine receptor alpha 3 | -6.73 | -6.91 | -6.84 | 17.39% | CHEMBL4070615 |
GLRA3_HUMAN | glycine receptor alpha 3 | -7.03 | N/A | N/A | 17.39% | CHEMBL4070615 |
GRM5_HUMAN | glutamate metabotropic receptor 5 | -6.82 | -7.94 | -8.10 | 38.54% | CHEMBL1682820 |
HPGDS_HUMAN | hematopoietic prostaglandin D synthase | -5.87 | -6.75 | -6.63 | 29.37% | CHEMBL4530713 |
HRH1_HUMAN | histamine receptor H1 | -6.98 | N/A | N/A | 40.43% | CHEMBL482496 |
HYES_HUMAN | epoxide hydrolase 2 | -5.91 | -6.56 | -6.36 | 43.59% | CHEMBL32969 |
IKKB_HUMAN | inhibitor of nuclear factor kappa B kinase subunit beta | -6.17 | N/A | N/A | 48.31% | CHEMBL3125821 |
MDR1_HUMAN | ATP binding cassette subfamily B member 1 | -5.81 | -6.38 | N/A | 53.33% | CHEMBL3632925 |
MIF_HUMAN | macrophage migration inhibitory factor | -6.21 | -6.10 | -5.97 | 32.20% | CHEMBL3797437 |
MK01_HUMAN | mitogen-activated protein kinase 1 | -5.56 | -5.67 | -5.85 | 40.70% | CHEMBL1909070 |
MK03_HUMAN | mitogen-activated protein kinase 3 | -6.39 | -6.20 | -5.59 | 28.75% | CHEMBL4291759 |
MTOR_HUMAN | mechanistic target of rapamycin kinase | -6.57 | -7.27 | -6.72 | 34.21% | CHEMBL4202641 |
NEP_HUMAN | membrane metalloendopeptidase | -6.66 | -6.16 | -6.65 | 34.23% | CHEMBL11620 |
NK1R_HUMAN | tachykinin receptor 1 | -6.62 | -6.45 | -6.03 | 45.88% | CHEMBL423597 |
NMDE1_HUMAN | glutamate ionotropic receptor NMDA type subunit 2A | -6.81 | -6.75 | -7.03 | 28.87% | CHEMBL284237 |
NMDE2_HUMAN | glutamate ionotropic receptor NMDA type subunit 2B | -7.22 | -7.47 | -7.23 | 51.90% | CHEMBL3357784 |
NMDZ1_HUMAN | glutamate ionotropic receptor NMDA type subunit 1 | -6.84 | -6.67 | -7.03 | 20.63% | CHEMBL419399 |
NOS1_HUMAN | nitric oxide synthase 1 | -7.06 | -7.10 | -6.34 | 36.61% | CHEMBL85613 |
NOS2_HUMAN | nitric oxide synthase 2 | -5.93 | -5.90 | -6.43 | 35.58% | CHEMBL1762475 |
NTRK1_HUMAN | neurotrophic receptor tyrosine kinase 1 | -7.47 | -7.31 | -7.06 | 28.67% | CHEMBL175321 |
OPRD_HUMAN | opioid receptor delta 1 | -5.78 | -5.55 | -5.46 | 51.52% | CHEMBL411 |
OPRK_HUMAN | opioid receptor kappa 1 | -7.01 | -7.01 | -6.57 | 52.56% | CHEMBL4472703 |
OPRM_MOUSE | Mu-type opioid receptor | -6.47 | -5.88 | N/A | 40.22% | CHEMBL146248 |
OPRX_HUMAN | opioid related nociceptin receptor 1 | -5.81 | -5.83 | -6.08 | 41.94% | CHEMBL233494 |
P2RX3_HUMAN | purinergic receptor P2X 3 | -4.43 | -4.20 | -4.36 | 29.85% | CHEMBL596234 |
P2Y12_HUMAN | purinergic receptor P2Y12 | -6.47 | -6.50 | -6.57 | 30.86% | CHEMBL25 |
PAR1_HUMAN | coagulation factor II thrombin receptor | -6.85 | N/A | N/A | 29.77% | CHEMBL80942 |
PDE4B_HUMAN | phosphodiesterase 4B | -6.57 | -6.88 | -6.78 | 42.27% | CHEMBL511115 |
PDE5A_HUMAN | phosphodiesterase 5A | -6.68 | -6.69 | -6.82 | 27.85% | CHEMBL422006 |
PERM_HUMAN | myeloperoxidase | -6.61 | -6.57 | -6.55 | 42.86% | CHEMBL3920217 |
PGH1_SHEEP | Prostaglandin G/H synthase 1 | -6.18 | -6.91 | -6.51 | 60.00% | CHEMBL229955 |
PGH2_HUMAN | prostaglandin-endoperoxide synthase 2 | -6.11 | -6.38 | -6.63 | 60.00% | CHEMBL229955 |
PPAP_HUMAN | acid phosphatase 3 | -5.53 | -5.64 | N/A | 29.13% | CHEMBL507996 |
PPARG_HUMAN | peroxisome proliferator activated receptor gamma | -5.94 | -5.93 | -5.97 | 47.96% | CHEMBL491820 |
PRGR_HUMAN | progesterone receptor | -6.26 | -6.53 | -6.50 | 51.81% | CHEMBL51788 |
PTGES_HUMAN | prostaglandin E synthase | -5.22 | N/A | N/A | 44.58% | CHEMBL140 |
SC6A4_HUMAN | solute carrier family 6 member 4 | -6.32 | -6.70 | -6.76 | 52.70% | CHEMBL3966886 |
SCN9A_HUMAN | sodium voltage-gated channel alpha subunit 9 | -7.00 | N/A | N/A | 37.74% | CHEMBL203440 |
TLR4_HUMAN | toll like receptor 4 | -6.82 | -6.47 | -6.07 | 34.68% | CHEMBL4076167 |
TNFA_HUMAN | tumor necrosis factor | -5.89 | -5.52 | -4.50 | 37.50% | CHEMBL63 |
TRBM_HUMAN | thrombomodulin | -5.68 | -4.94 | N/A | N/A | N/A |
TRPM4_HUMAN | transient receptor potential cation channel subfamily M member 4 | -5.16 | -5.31 | N/A | 19.84% | CHEMBL1408302 |
TRPM8_FICAL | Uncharacterized protein | -6.86 | N/A | N/A | N/A | N/A |
TRPV1_RAT | Transient receptor potential cation channel subfamily V member 1 | -6.71 | N/A | N/A | 40.86% | CHEMBL2057857 |
TRPV2_RABIT | Transient receptor potential cation channel subfamily V member 2 | -6.34 | -5.90 | N/A | N/A | N/A |
TRPV3_HUMAN | transient receptor potential cation channel subfamily V member 3 | -5.82 | -5.88 | N/A | 29.08% | CHEMBL3664218 |
TRXR1_HUMAN | thioredoxin reductase 1 | -5.56 | -5.36 | -4.84 | 19.57% | CHEMBL4459518 |
TRY1_HUMAN | serine protease 1 | -4.68 | N/A | N/A | 38.89% | CHEMBL320817 |